Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.

about

Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril

P2860

Q27660250-8DD28048-2B99-4638-B0FA-83C1DD8A61F2

P2860

Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.

Item

http://www.wikidata.org/entity/Q34512406

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@ast

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@en

Novel ketomethylene inhibitors of angiotensin I-converting enzyme

@nl

type

Item

label

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@ast

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@en

Novel ketomethylene inhibitors of angiotensin I-converting enzyme

@nl

prefLabel

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@ast

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@en

Novel ketomethylene inhibitors of angiotensin I-converting enzyme

@nl

P1476

Novel ketomethylene inhibitors ...... ition and molecular modelling.

@en

P2093

Aloysius T Nchinda

http://www.w3.org/2001/XMLSchema#string

Edward D Sturrock

http://www.w3.org/2001/XMLSchema#string

Pierre Redelinghuys

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the human angiotensin-converting enzyme-lisinopril complex

Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

The preparation and function of the hypertensin-converting enzyme.

Ace revisited: a new target for structure-based drug design.

Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.

Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Identification of N-linked glycosylation sites in human testis angiotensin-converting enzyme and expression of an active deglycosylated form.

Angiotensin-converting enzyme: new concepts concerning its biological role.

An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.

P304

461-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/BC.2006.061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

387

http://www.w3.org/2001/XMLSchema#string

P50

Kelly Chibale

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16606345

http://www.w3.org/2001/XMLSchema#string

Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.

about

P2860

P2860

Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698